Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

Clinical trial NCT06554288 · RECRUITING

Trial details

NCT number: NCT06554288
Sponsor: Children's Mercy Hospital Kansas City
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Disorder Genetic Predisposition Dystonia, Secondary Dystonia Cerebral Palsy, Dystonic-Rigid Cerebral Palsy, Dyskinetic Trihexyphenidyl Adverse Reaction Pharmacogenomic Drug Interaction

Start date: 2024-10-15
Primary completion: 2029-11-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.